Regeneron and Sanofi Announce Intent to Restructure Antibody Collaboration for Kevzara and Praluent
Regeneron Pharmaceuticals and Sanofi announced their intent to simplify their antibody collaboration for Kevzara (sarilumab) and Praluent (alirocumab) by restructuring into a…
Read More...
Read More...
